Voyageur Pharmaceuticals’ X-Ray Contrast Media Provides a Dramatic Increase in Valuation https://investorintel.com/markets/biotech-healthcare/biotech-intel/voyageur-pharmaceuticals-x-ray-contrast-media-provides-a-dramatic-increase-in-valuation/ brent_adm2022-01-12T09:09:39-07:00January 12th, 2022|Read More
Alberta Veterinarian Laboratories Drug Establishment Licence https://www.newswire.ca/news-releases/calgary-facility-receives-drug-establishment-license-836677526.html brent_adm2021-04-29T17:23:59-06:00April 29th, 2021|Read More
Drug Supply Becoming Strategic Issue For North America https://www.washingtonexaminer.com/policy/defense-national-security/play-dirty-chinese-official-threatens-us-medical-supplies-over-huawei-fight brent_adm2020-08-28T11:40:51-06:00August 28th, 2020|Read More
Voyageur Summer Summary Voyageur Summer Strategy brent_adm2020-08-25T18:15:35-06:00August 25th, 2020|Read More
Fullerene Study – Fullerenes in biology and medicine Fullerene Study – Fullerenes in biology and medicine brent_adm2020-05-08T17:41:50-06:00May 8th, 2020|Read More
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company – $0.39 Fair Market Value Target Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company – $0.39 Fair Market Value Target Darin2020-01-13T13:25:15-07:00January 13th, 2020|Read More
